Genentech   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: South San Francisco CA United States (1976)
Status: Acquired by Roche (2009)

Organization Overview

First Clinical Trial
1992
Unregistered Trial 187086
First Marketed Drug
1979
somatropin (protropin)
First NDA Approval
1985
growth hormone (Protropin)
Last Known Activity
2024

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

GENENTECH | Genentech and Biogen IDEC | Genentech, Inc. | GENENTECH INC | Genentech, Inc., University of Colorado Denver, National Jewish, Beth Israel Deaconess Medical Center, and Long Island Jewish Hospital | Genentech/Roche | Genentech (South San Francisco, California, USA) | Genetech